| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292889 | Gastroenterology | 2012 | 12 Pages |
Abstract
Following induction therapy with adalimumab, patients with moderately to severely active CD who continue to receive adalimumab are more likely to achieve mucosal healing than those given placebo.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Paul Rutgeerts, Gert Van Assche, William J. Sandborn, Douglas C. Wolf, Karel Geboes, Jean-Frédéric Colombel, Walter Reinisch, EXTEND Investigators EXTEND Investigators, Ashish Kumar, Andreas Lazar, Anne Camez, Kathleen G. Lomax, Paul F. Pollack,